You searched for metabolic diseases - Page 2 of 64

In Depth 19 Jun 2024

MASH candidates make a splash after first drug approval

…few societies as the most accurate way to describe the disease.” New treatments related to metabolic diseases ⁠⁠Indacaterol for the Treatment Obesity and Related Metabolic Diseases – Texas Tech University…

June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 13 Feb 2025

Seven companies using metabolomics to decode biology

…been instrumental in diagnostic applications, its impact extends into therapeutic development. By elucidating metabolic alterations associated with diseases, metabolomics enables the design of targeted interventions, enhancing the precision and effectiveness…

February 13, 2025 - 9 minutesmins - By Jules Adam

News and Trends 22 Sep 2022

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

…development of HU6 and a pipeline of controlled metabolic accelerators to address a range of cardio-metabolic conditions.” About Rivus Pharmaceuticals’ CMAs Nearly half of American adults are living with cardio-metabolic…

September 22, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…involvement in various diseases – alterations in miRNA expression profiles have been linked to cancer, cardiovascular diseases, and neurodegenerative disorders. This connection positions miRNAs as both potential biomarkers for disease…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 2 Jul 2025

Top biotech deals in June 2025

…a special interest in curing metabolic diseases, most of the medicines up for grabs were small molecules, proteins, and antibodies. Take a look at the top biotech deals that were…

July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…in metabolic diseases continue As always, interest in targeting metabolic diseases remains strong. And once again, Lilly is in the game. It has partnered with insitro, a California-based drug company,…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

…across the medical spectrum and include cancers, neurological and neuromuscular diseases, metabolic diseases and a multitude of skin, bone, kidney, blood and skeletal disorders. Many have genetic origins, and some…

February 28, 2023 - 6 minutesmins - By External Contributor

In Depth 19 May 2023

Can cardiovascular diseases be cured? The future of heart treatment

…over the years increasing our understanding of different types of cardiovascular diseases and their causes. What are the challenges in developing cures for cardiovascular diseases? One of the main challenges…

May 19, 2023 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 29 Oct 2024

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

…of diseases like autoimmune disorder Graves’ disease – caused by excess thyroid hormone production – chronic spontaneous urticaria – a skin condition that causes hives – and metabolic diseases. Structure…

October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

In Depth 25 Jan 2024

The trends that will shape the biotech industry in 2024

…mingled with other metabolic diseases, GLP-1 drugs will replace Lipitors. Furthermore, scientific findings about mitochondria are exciting as they show it is related to many diseases and complications. Aging relates…

January 25, 2024 - 13 minutesmins - By Jules Adam

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

…aggregated proteins. This strategy is particularly important for diseases where multiple proteinopathies – conditions caused by the accumulation of malfunctioning proteins – are present simultaneously, as seen in neurodegenerative diseases…

October 15, 2024 - 6 minutesmins - By Jules Adam

News and Trends 9 Jan 2017

Top European VC and CRO fund Young Metabolic Disease Biotech

…in Berlin focusing on the treatment of metabolic diseases. The company has now raised €8M in Series A, led by Scottish biotech VC Epidarex Capital. Among the investors was also…

January 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

MASH candidates make a splash after first drug approval

Seven companies using metabolomics to decode biology

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

Seven miRNA-focused companies pioneering new therapies in 2024

Top biotech deals in June 2025

Top biotech deals of October 2024

Life changing treatments for rare disease – a beacon of hope

Can cardiovascular diseases be cured? The future of heart treatment

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

The trends that will shape the biotech industry in 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

Top European VC and CRO fund Young Metabolic Disease Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!